This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Optum, Mayo Clinic Partner To Launch Optum Labs: An Open, Collaborative Research And Innovation Facility Focused On Better Care For Patients

Optum and Mayo Clinic today jointly launched Optum Labs, an open, collaborative research and development facility with a singular goal: improving patient care. Based in Cambridge, Mass., Optum Labs provides an environment where the health care industry can come together to combine information and ideas that benefit patients today while also driving long-term improvements in the delivery and quality of care.

Optum and Mayo Clinic will make their information assets, technologies, knowledge tools and scientific expertise available to organizations interested in pursuing practical new solutions to patient care challenges. As the first and largest integrated, not-for-profit medical group practice in the world, Mayo Clinic will also contribute valuable insights directly from patient experiences. Mayo Clinic’s extensive clinical expertise will be instrumental in guiding Optum Labs’ research agenda and applying research results and insights directly to the patient care environment. Combining Mayo Clinic’s extensive clinical insights with Optum’s health care claims information will help doctors better understand all aspects of the patient care experience and refine approaches to care that consistently help patients achieve the best outcomes. Other Optum Labs participants will include academic institutions, life sciences companies, commercial and government payers, and other care providers.

“As a founding partner of Optum Labs, Mayo Clinic is excited to work with Optum and other organizations to address the challenges and issues facing health care in order to help us provide better care to our patients, and help lead improvements to the delivery of care,” said John Noseworthy, M.D., president and chief executive officer of Mayo Clinic. “Our strategic research alliance with Optum Labs will leverage what we believe to be the largest combined source of clinical and claims information, providing a more comprehensive picture of patients’ diagnoses, progression of diseases, comparative treatments and outcomes.”

“We are privileged to introduce Optum Labs in partnership with Mayo Clinic, which has been improving health outcomes for 150 years by continually researching, discovering and doing what’s best for the patient,” said Larry Renfro, chief executive officer of Optum. “Mayo Clinic and Optum are bringing together the best clinical insight, health information and research expertise to drive innovation that works for care providers and the patients they serve. We also welcome and look forward to the perspectives, ideas and contributions of future participants from across the health care system who share the goal of creating a better future for patient care.”

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,683.58 -46.53 -0.26%
S&P 500 2,068.76 -8.02 -0.39%
NASDAQ 4,991.94 -17.2740 -0.34%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs